Glutathione-activated prodrug-based self-delivering nanomedicines for tumoricidal chemo-photodynamic synergistic therapy
- 12 December 2025
- journal article
- Published by Elsevier in Journal of Colloid and Interface Science
- Vol. 707, 139682
Abstract
No abstract availableKeywords
Funding Information
- National Natural Science Foundation of China (32071396)
- Natural Science Foundation of Jiangxi Province (20252BAC200590)
This publication has 49 references indexed in Scilit:
- Satellite‐Type Sulfur Atom Distribution in Trithiocarbonate Bond‐Bridged Dimeric Prodrug Nanoassemblies: Achieving Both Stability and ActivatabilityAdvanced Materials, 2023
- Ferric Ion‐Driven Chlorin E6 Nanoparticles: Simple and Effective Multimodal TheranosticsAdvanced Functional Materials, 2023
- Recent advances in long-acting drug delivery systems for anticancer drugAdvanced Drug Delivery Reviews, 2023
- Light-triggered photodynamic nanomedicines for overcoming localized therapeutic efficacy in cancer treatmentAdvanced Drug Delivery Reviews, 2022
- Tumor-activated carrier-free prodrug nanoparticles for targeted cancer Immunotherapy: Preclinical evidence for safe and effective drug deliveryAdvanced Drug Delivery Reviews, 2022
- Delivering more for less: nanosized, minimal-carrier and pharmacoactive drug delivery systemsAdvanced Drug Delivery Reviews, 2021
- Probing the Superiority of Diselenium Bond on Docetaxel Dimeric Prodrug Nanoassemblies: Small Roles Taking Big ResponsibilitiesSmall, 2020
- A Metal–Polyphenol‐Coordinated Nanomedicine for Synergistic Cascade Cancer Chemotherapy and Chemodynamic TherapyAdvanced Materials, 2019
- Creation of Pure Nanodrugs and Their Anticancer PropertiesAngewandte Chemie International Edition, 2012
- Controlling drug nanoparticle formation by rapid precipitationAdvanced Drug Delivery Reviews, 2011